Skip to content

Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles

Impact of Serum Progesterone Levels on the Day of Embryo Transfer on the Success Rate in Egg Donation Cycles Under Hormonal Replacement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02696694
Enrollment
242
Registered
2016-03-02
Start date
2016-02-29
Completion date
2016-10-31
Last updated
2016-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Brief summary

This study aims to investigate the impact of serum progesterone concentrations on the day of embryo transfer in egg donation cycles under hormonal replacement therapy. As secondary outcomes, the investigators will investigate if endometrial volume measured by three-dimensional (3D) ultrasound on the day of embryo transfer is related with progesterone levels and with chances of pregnancy.

Interventions

OTHERProgesterone 25-75

Impact of serum progesterone concentrations \[25-75\] on the day of embryo transfer in egg donation cycles under hormonal replacement therapy

OTHERProgesterone <25, >75

Impact of serum progesterone concentrations (\<25, \>75) on the day of embryo transfer in egg donation cycles under hormonal replacement therapy

Sponsors

Instituto Valenciano de Infertilidad, IVI VALENCIA
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age\<50 yo * BMI \< 30Kg/m2 * Hormonal replacement cycle * Endometrial thickness \>6.5 mm during proliferative phase * Transfer of one or two blastocyst grade A-B according to ASEBIR

Exclusion criteria

* Uterine pathology * Cryptozoospermia * Severe implantation failure (\>6 GQ embryos transferred without success)

Design outcomes

Primary

MeasureTime frame
mid-luteal serum progesterone levelone year

Secondary

MeasureTime frame
endometrial volumeone year

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026